Nektar Therapeutics (Nasdaq: NKTR) announced that it has entered into an agreement with Daiichi Sankyo Europe for Nektar's investigational drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE